Category Archives: Pr Newswire

Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant

Phase 2 data demonstrate differentiated CXCR4 inhibition kinetics enabling same-day cell collection, with rapid lymphocyte mobilization supporting potential therapeutic applications beyond transplant REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 […]

Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences

SAN MATEO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, NY, on February 11, 2026, with a fireside […]

Mantle’s Evolution Into an Institutional Distribution Layer for Onchain Finance, Marked by 37% QoQ TVL Growth in Messari Report

DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ — Messari has released its State of Mantle Q4 2025 report, providing an in-depth analysis of Mantle’s network design, treasury strategy, and ecosystem development as the protocol advances its role as a coordinated distribution layer for institutional onchain finance. Mantle’s Evolution Into an Institutional Distribution Layer for Onchain Finance, […]

Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan

TOKYO and SHANGHAI, Feb. 5, 2026 /PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO: Jason Zhu, “Henlius”) announced today the conclusion of an exclusive commercialization and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab (generic name, marketed as HANSIZHUANG in China and Hetronifly® in the EU) in Japan. […]

Only Small Group of Banks Are Turning AI into Revenue, New Research Finds

SINGAPORE, Feb. 5, 2026 /PRNewswire/ — Dyna.Ai, a global provider of AI solutions, today released a new executive insights report, developed in collaboration with GXS Partners and Smartkarma, examining why most banks struggle to translate AI investment into revenue, and how a small group is breaking through. The report highlights how financial institutions across Southeast Asia, […]

TAT announces Amazing Thailand Chinese New Year 2026 in Bangkok and Hat Yai marking 51 years of Thailand-China relations

A nationwide programme is expected to stimulate travel demand and generate more than 42 billion Baht in tourism revenue BANGKOK, Feb. 5, 2026 /PRNewswire/ — The Tourism Authority of Thailand (TAT) today announced Amazing Thailand Chinese New Year 2026, marking the Golden Horse year and the 51st anniversary of Thailand–China diplomatic relations. Anchored by flagship events […]

Leading Chinese Innovative Medical Device Maker Insight Lifetech Has Successfully Listed on STAR Market

SHANGHAI, Feb. 5, 2026 /PRNewswire/ — Insight Lifetech, a portfolio company of Qiming Venture Partners and a leading Chinese innovative medical device manfaucturer, successfully listed on the Shanghai Stock Exchange’s STAR Market on February 5, 2026 Beijing time. Insight Lifetech (688712.SH) issued shares at a price of CNY17.52 per share and opened at CNY50.31 per share […]

Max Force Power Male Enhancement Gummies Product Information Updated as Consumer Interest in Male Vitality Supplement Options Grows in 2026

An informational overview examining male enhancement supplement category trends, publicly available ingredient disclosures, consumer evaluation criteria, and what adults researching male vitality supplement options often consider when comparing label transparency and manufacturing standards in 2026 MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical […]

XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that further to its press release of October 17, 2025 and an update […]

MEN Balance Pro Consumer Report (2026): Public Product Information and Evaluation Factors (Not a Review)

An informational overview examining MEN Balance Pro refund policy terms, retailer disclosures, ingredient transparency, and what consumers evaluate when researching men’s wellness supplement options in 2026 WILMINGTON, DE, Feb. 04, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical advice. Men’s health and wellness concerns should be evaluated […]